• Sab. Lug 27th, 2024

research

  • Home
  • Understanding the benefits of GLP-1 drugs beyond obesity

Understanding the benefits of GLP-1 drugs beyond obesity

In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including…

TG SALUTEDOMANI TV: ARTIFICIAL INTELLIGENCE FALSE PREDICTIONS, PLITIDEPSIN REEVALUATION IN MULTIPLE MYELOMA

WHEN TO TRUST AN ARTIFICIAL INTELLIGENCE AI MODEL Because machine-learning models can give false predictions, researchers often equip them with the ability to tell a user how confident they are…

Insights into Alzheimer’s disease mechanisms through novel hydrogel matrix

Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have unveiled a pioneering study shedding light on the intricate mechanisms underlying Alzheimer’s disease (AD). The study, titled “Effects of amyloid-β-mimicking…

Immunotherapy approach shows potential in some people with metastatic solid tumors

Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic solid tumors. In the trial, researchers from the National…

Only one in 20 therapies tested in animals reach approval for human use

An analysis of reviews of translational biomedical research reveals that just 5% of therapies tested in animals reach regulatory approval for human use. The study, an umbrella review, published June…

Advancing personalised, data-​driven medicine. ETH Zurich’ s new BSS teaching and research building

When ETH Zurich established a new department in 2007 – in Basel, no less – with the aim of bringing together researchers from three disciplines, the idea was considered daring.…

TG SALUTEDOMANI TV: VACCINE AND CANCERS, MICROPLASTICS, ELECTRONIC SKIN

ONE VACCINE, MANY CANCERS In a new study published in Blood Advances, researchers from the UChicago Pritzker School of Molecular Engineering’s Hubbell Lab created with a novel approach to develop…

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Colorized scanning electron micrograph of mpox virus particles (blue) on the surface of infected VERO E6 cells (pink). NIAID A dose-sparing intradermal mpox vaccination regimen was safe and generated an…

A vaccine to fight antibiotic resistance

Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It’s estimated that antimicrobial-resistant infections killed more than 1 million people worldwide in 2019, according…

Artificial intelligence detects heart defects in newborns

Many children announce their arrival in the delivery room with a piercing cry. As a newborn automatically takes its first breath, the lungs inflate, the blood vessels in the lungs…